眼部恶性瘤中的极光基因:功能意义和潜在影响
Saswati S Lenka1, Naheed Arfin Borah1,2, Soumya Sucharita3
1The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Mithu Tulsi Chanrai Campus, Bhubaneswar, India.
Ocular oncology and pathology
|December 18, 2025
概括
极光激酶 (AURKA和AURKB) 是视网膜母细胞瘤 (RB) 和脑膜黑色素瘤 (UM) 眼部瘤进展的关键驱动因素. 抑制这些激酶为罕见的眼睛癌症提供了一个有希望的新疗法策略.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 眼部恶性瘤很少见,治疗选择有限,主要涉及化疗,放射和手术.
- 这些罕见的瘤在历史上与其他癌症相比,研究关注度较低.
- 最近的研究重点关注分子途径,以开发针对眼癌的向治疗方法.
研究的目的:
- 审查极光激酶 (AURKs) 在眼部瘤进展中的作用.
- 讨论针对AURKs,特别是AURKA和AURKB,作为视网膜母细胞瘤 (RB) 和皮膜黑色素瘤 (UM) 的治疗策略的潜力.
主要方法:
- 文献综述,重点关注正常和癌细胞中的极光激酶功能.
- 对包括RB和UM在内的眼部恶性瘤中AURK失调的分析.
- 探索目前用于极光酶抑制的治疗方法.
主要成果:
- 极光激酶 (AURKA和AURKB) 是RB和UM中瘤进展的关键调节者.
- AURKs的失调与这些眼部癌症的发展和进展有关.
- 极光激酶抑制显示了治疗RB和UM的治疗潜力.
结论:
- 针对AURKA和AURKB代表了罕见的眼睛恶性瘤的新治疗途径.
- 对极光激酶抑制的进一步研究可能会提高RB和UM患者的治疗疗效.
- 了解眼癌的分子驱动因素对于开发有效的向疗法至关重要.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K


